Page last updated: 2024-10-15

dihydropteroate

Description

dihydropteroate: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

7,8-dihydropteroic acid : A pteroic acid derivative arising from formal hydrogenation of the 7,8-double bond of pteroic acid. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

7,8-dihydropteroate : A pteroate that is the conjugate base of 7,8-dihydropteroic acid, arising from deprotonation of the carboxy group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID135398662
CHEMBL ID1614805
CHEBI ID4581
SCHEMBL ID609952
SCHEMBL ID13772569
MeSH IDM0040992

Synonyms (30)

Synonym
dihydropteroinsaeure
4-{[(2-amino-4-oxo-3,4,7,8-tetrahydropteridin-6-yl)methyl]amino}benzoic acid
CHEBI:4581 ,
h2pte
dihydropterate
benzoic acid, 4-[[(2-amino-1,4,7,8-tetrahydro-4-oxo-6-pteridinyl)methyl]amino]-
dihydropteroic acid
4-(((2-amino-1,4,7,8-tetrahydro-4-oxo-6-pteridinyl)methyl)amino)benzoic acid
2134-76-1
7,8-dihydropteroic acid
7,8-dihydropteroate
C00921
dihydropteroate
CHEMBL1614805
unii-y3gl4v652e
y3gl4v652e ,
SCHEMBL609952
SCHEMBL13772569
DTXSID40175605
p-[[(2-amino-7,8-dihydro-4-hydroxy-6-pteridinyl)methyl]amino]-benzoate
4-[[(2-amino-3,4,7,8-tetrahydro-4-oxo-6-pteridinyl)methyl]amino]-benzoate
p-[[(2-amino-7,8-dihydro-4-hydroxy-6-pteridinyl)methyl]amino]-benzoic acid
4-[[(2-amino-1,4,7,8-tetrahydro-4-oxo-6-pteridinyl)methyl]amino]-benzoic acid
4-[[(2-amino-3,4,7,8-tetrahydro-4-oxo-6-pteridinyl)methyl]amino]-benzoic acid
4-[[(2-amino-1,4,7,8-tetrahydro-4-oxo-6-pteridinyl)methyl]amino]-benzoate
Q5276444
4-[(2-amino-4-oxo-7,8-dihydro-3h-pteridin-6-yl)methylamino]benzoic acid
benzoic acid, 4-[[(2-amino-3,4,7,8-tetrahydro-4-oxo-6-pteridinyl)methyl]amino]-
4-((2-azanyl-4-oxidanylidene-7,8-dihydro-1h-pteridin-6-yl)methylamino)benzoic acid
4-(((2-amino-4-oxo-1,4,7,8-tetrahydropteridin-6-yl)methyl)amino)benzoic acid
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
pteroic acids
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (6)

PathwayProteinsCompounds
Folate metabolism ( Folate metabolism )2039
tetrahydrofolate biosynthesis I028
formylTHF biosynthesis II027
formylTHF biosynthesis I026
Folate biosynthesis08
Folate biosynthesis029
Tetrahydrofolate biosynthesis II128

Bioassays (2)

Assay IDTitleYearJournalArticle
AID1146782Reversal of sulfapyridine-mediated growth inhibition of Escherichia coli at 4 to 400 umol/l1977Journal of medicinal chemistry, Mar, Volume: 20, Issue:3
P-Aminobenzoic acid derivatives. Mode of action and structure-activity relationships in a cell-free system (Escherichia coli).
AID1146783Reversal of sulfabenzene-mediated growth inhibition of Escherichia coli at 4 to 400 umol/l1977Journal of medicinal chemistry, Mar, Volume: 20, Issue:3
P-Aminobenzoic acid derivatives. Mode of action and structure-activity relationships in a cell-free system (Escherichia coli).
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (17)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (29.41)18.7374
1990's1 (5.88)18.2507
2000's7 (41.18)29.6817
2010's4 (23.53)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (11.76%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other15 (88.24%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]